Clinical Trial

Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research. Phase 3a Survey

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by "turning on" or "turning off" certain genes through a process called "epigenetic modification." This study will develop and test strategies for communicating about epigenetics that are understandable and that do not increase ethical, legal or social issues (ELSI).
Trial Details
NCT Number NCT07713667
Lead Sponsor Washington University School of Medicine
Collaborators: National Institute of Environmental Health Sciences (NIEHS)
Conditions Healthy
Enrollment 1,000 participants
Start Date 2026-08-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-20